SCHEMBL4019568

SCHEMBL4019568

C1=CCC([Ru]c2ncc[nH]2)=C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4026070 0.83
SCHEMBL4018491 0.80 ADRA2A (0.30)
SCHEMBL4022412 0.73 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2
SCHEMBL52936 0.71
SCHEMBL4023391 0.69 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2
SCHEMBL4021902 0.66
SCHEMBL4025045 0.66 TAAR1 (0.31)
SCHEMBL4023345 0.66
SCHEMBL2005078 0.66
Carbon Monoxide SCHEMBL9218219 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090200524-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-13 US claimed
US-20090203917-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-13 US claimed
US-20090202740-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-13 US claimed
WO-2009094259-A1 ORGANOMETALLIC COMPOUNDS PROCESSES AND METHODS OF USE PRAXAIR TECHNOLOGY, INC. (US) 2009-07-30 WO claimed
US-20090203917-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-13 US disclosed
US-20090200524-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-13 US disclosed
US-20090202740-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF PRAXAIR TECHNOLOGY, INC. 2009-08-13 US disclosed
WO-2009094259-A1 ORGANOMETALLIC COMPOUNDS PROCESSES AND METHODS OF USE PRAXAIR TECHNOLOGY, INC. (US) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203917-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF L1CAM, TLL2, LANCL2 ALDH1A1 1712/4885SMN1; SMN2 1445/4885
US-20090200524-A1 ORGANOMETALLIC COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND METHODS OF USE THEREOF L1CAM, TLL2, LANCL2 ALDH1A1 1712/4885SMN1; SMN2 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.